Focal cortical dysplasia (FCD) represents the most common cause of drug-resistant epilepsy in adult and pediatric surgical series. However, genetic factors contributing to severe phenotypes of FCD remain unknown. We present a patient with an exceptionally rapid development of drug-resistant epilepsy evolving in super-refractory status epilepticus. We performed multiple clinical (serial EEG, MRI), biochemical (metabolic and immunological screening), genetic (WES from blood- and brain-derived DNA), and histopathological investigations. The patient presented 1 month after an uncomplicated varicella infection. MRI was negative, as well as other biochemical and immunological examinations. Whole-exome sequencing of blood-derived DNA detected a heterozygous paternally inherited variant NM_006267.4(RANBP2):c.5233A>G p.(Ile1745Val) (Chr2[GRCh37]:g.109382228A>G), a gene associated with a susceptibility to infection-induced acute necrotizing encephalopathy. No combination of anti-seizure medication led to a sustained seizure freedom and the patient warranted induction of propofol anesthesia with high-dose intravenous midazolam and continuous respiratory support that however failed to abort seizure activity. Brain biopsy revealed FCD type IIa; this finding led to the indication of an emergency right-sided hemispherotomy that rendered the patient temporarily seizure-free. Postsurgically, he remains on antiseizure medication and experiences rare nondisabling seizures. This report highlights a uniquely severe clinical course of FCD putatively modified by the RANBP2 variant. PLAIN LANGUAGE SUMMARY: We report a case summary of a patient who came to our attention for epilepsy that could not be controlled with medication. His clinical course progressed rapidly to life-threatening status epilepticus with other unusual neurological findings. Therefore, we decided to surgically remove a piece of brain tissue in order to clarify the diagnosis that showed features of a structural brain abnormality associated with severe epilepsy, the focal cortical dysplasia. Later, a genetic variant in a gene associated with another condition, was found, and we hypothesize that this genetic variant could have contributed to this severe clinical course of our patient.

2nd Faculty of Medicine Charles University Prague Czech Republic

Department of Biology and Medical Genetics Motol University Hospital and 2nd Faculty of Medicine Charles University Prague Czech Republic

Department of Clinical Psychology Motol University Hospital and 2nd Faculty of Medicine Charles University Prague Czech Republic

Department of Neurosurgery Motol University Hospital and 2nd Faculty of Medicine Charles University Prague Czech Republic

Department of Paediatric Neurology Motol University Hospital and 2nd Faculty of Medicine Charles University Prague Czech Republic

Department of Pathology and Molecular Medicine Motol University Hospital and 2nd Faculty of Medicine Charles University Prague Czech Republic

Department of Radiology Motol University Hospital and 2nd Faculty of Medicine Charles University Prague Czech Republic

Zobrazit více v PubMed

Blumcke I, Spreafico R, Haaker G, Coras R, Kobow K, Bien CG, et al. Histopathological findings in brain tissue obtained during epilepsy surgery. N Engl J Med. 2017;377(17):1648–1656. PubMed

Krsek P, Pieper T, Karlmeier A, Hildebrandt M, Kolodziejczyk D, Winkler P, et al. Different presurgical characteristics and seizure outcomes in children with focal cortical dysplasia type I or II. Epilepsia. 2009;50(1):125–137. PubMed

Barba C, Blumcke I, Winawer MR, Hartlieb T, Kang HC, Grisotto L, et al. Clinical features, neuropathology, and surgical outcome in patients with refractory epilepsy and brain somatic variants in the SLC35A2 gene. Neurology. 2022;100:e528–e542. PubMed PMC

Straka B, Splitkova B, Vlckova M, Tesner P, Rezacova H, Krskova L, et al. Genetic testing in children enrolled in epilepsy surgery program. A real‐life study. Eur J Paediatr Neurol. 2023;47:80–87. PubMed

Sanders M, Lemmens CMC, Jansen FE, Brilstra EH, Koeleman BPC, Braun KPJ. Implications of genetic diagnostics in epilepsy surgery candidates: a single‐center cohort study. Epilepsia Open. 2019;4(4):609–617. PubMed PMC

Stevelink R, Sanders M, Tuinman MP, Brilstra EH, Koeleman BPC, Jansen FE, et al. Epilepsy surgery for patients with genetic refractory epilepsy: a systematic review. Epileptic Disord. 2018;20(2):99–115. PubMed

Palmini A, Najm I, Avanzini G, Babb T, Guerrini R, Foldvary‐Schaefer N, et al. Terminology and classification of the cortical dysplasias. Neurology. 2004;62(6 Suppl 3):S2–S8. PubMed

Blumcke I, Thom M, Aronica E, Armstrong DD, Vinters HV, Palmini A, et al. The clinicopathologic spectrum of focal cortical dysplasias: a consensus classification proposed by an ad hoc task force of the ILAE diagnostic methods commission. Epilepsia. 2011;52(1):158–174. PubMed PMC

Karczewski KJ, Francioli LC, Tiao G, Cummings BB, Alfoldi J, Wang Q, et al. The mutational constraint spectrum quantified from variation in 141,456 humans. Nature. 2020;581(7809):434–443. PubMed PMC

Belohlavkova A, Jezdik P, Jahodova A, Kudr M, Benova B, Maulisova A, et al. Evolution of pediatric epilepsy surgery program over 2000–2017: improvement of care? Eur J Paediatr Neurol. 2019;23(3):456–465. PubMed

Guerrini R, Cavallin M, Pippucci T, Rosati A, Bisulli F, Dimartino P, et al. Is focal cortical dysplasia/epilepsy caused by somatic MTOR mutations always a unilateral disorder? Neurol Genet. 2021;7(1):e540. PubMed PMC

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier‐Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17(5):405–424. PubMed PMC

Hartley M, Sinha A, Kumar A, Aliu E, Mainali G, Paudel S. Acute necrotizing encephalopathy: 2 case reports on RANBP2 mutation. Child Neurol Open. 2021;8:2329048X211030751. PubMed PMC

Levine JM, Ahsan N, Ho E, Santoro JD. Genetic acute necrotizing encephalopathy associated with RANBP2: clinical and therapeutic implications in pediatrics. Mult Scler Relat Disord. 2020;43:102194. PubMed PMC

Chatur N, Yea C, Ertl‐Wagner B, Yeh EA. Outcomes in influenza and RANBP2 mutation‐associated acute necrotizing encephalopathy of childhood. Dev Med Child Neurol. 2022;64(8):1008–1016. PubMed

Denier C, Balu L, Husson B, Nasser G, Burglen L, Rodriguez D, et al. Familial acute necrotizing encephalopathy due to mutation in the RANBP2 gene. J Neurol Sci. 2014;345(1–2):236–238. PubMed

Neilson DE, Eiben RM, Waniewski S, Hoppel CL, Varnes ME, Bangert BA, et al. Autosomal dominant acute necrotizing encephalopathy. Neurology. 2003;61(2):226–230. PubMed

Gika AD, Rich P, Gupta S, Neilson DE, Clarke A. Recurrent acute necrotizing encephalopathy following influenza a in a genetically predisposed family. Dev Med Child Neurol. 2010;52(1):99–102. PubMed

Neilson DE, Adams MD, Orr CM, Schelling DK, Eiben RM, Kerr DS, et al. Infection‐triggered familial or recurrent cases of acute necrotizing encephalopathy caused by mutations in a component of the nuclear pore, RANBP2. Am J Hum Genet. 2009;84(1):44–51. PubMed PMC

Singh RR, Sedani S, Lim M, Wassmer E, Absoud M. RANBP2 mutation and acute necrotizing encephalopathy: 2 cases and a literature review of the expanding clinico‐radiological phenotype. Eur J Paediatr Neurol. 2015;19(2):106–113. PubMed

Lönnqvist T, Isohanni P, Valanne L, Olli‐Lähdesmäki T, Suomalainen A, Pihko H. Dominant encephalopathy mimicking mitochondrial disease. Neurology. 2011;76(1):101–103. PubMed

Lai D, Gade M, Yang E, Koh HY, Lu J, Walley NM, et al. Somatic variants in diverse genes leads to a spectrum of focal cortical malformations. Brain. 2022;145:2704–2720. PubMed PMC

Barba C, Blumcke I, Winawer MR, Hartlieb T, Kang HC, Grisotto L, et al. Clinical features, neuropathology, and surgical outcome in patients with refractory epilepsy and brain somatic variants in the SLC35A2 gene. Neurology. 2023;100(5):e528–e542. PubMed PMC

Blumcke I, Cendes F, Miyata H, Thom M, Aronica E, Najm I. Toward a refined genotype‐phenotype classification scheme for the international consensus classification of focal cortical dysplasia. Brain Pathol. 2021;31(4):e12956. PubMed PMC

Benova B, Jacques TS. Genotype‐phenotype correlations in focal malformations of cortical development: a pathway to integrated pathological diagnosis in epilepsy surgery. Brain Pathol. 2019;29(4):473–484. PubMed PMC

Najm I, Lal D, Alonso Vanegas M, Cendes F, Lopes‐Cendes I, Palmini A, et al. The ILAE consensus classification of focal cortical dysplasia: an update proposed by an ad hoc task force of the ILAE diagnostic methods commission. Epilepsia. 2022;63:1899–1919. PubMed PMC